Brazilian (BOVESPA) Pharma Industry Analysis
UpdatedMay 08, 2024
DataAggregated Company Financials
Companies2
- 7D2.2%
- 3M-5.8%
- 1Y-21.4%
- YTD-14.1%
In the last week, the Pharma industry is up 1.8%, with all of the companies up. However, the industry is down 22% over the past year. Earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the Brazilian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 08 May 2024 | R$20.3b | R$9.0b | R$1.7b | 11.2x | 12.3x | 2.3x |
| Fri, 05 Apr 2024 | R$21.3b | R$8.9b | R$1.6b | 12.1x | 13.3x | 2.4x |
| Sun, 03 Mar 2024 | R$22.8b | R$9.2b | R$1.7b | 12.2x | 13.1x | 2.5x |
| Tue, 30 Jan 2024 | R$20.9b | R$9.2b | R$1.7b | 11.4x | 12x | 2.3x |
| Thu, 28 Dec 2023 | R$24.2b | R$9.2b | R$1.7b | 12.9x | 13.8x | 2.6x |
| Sat, 25 Nov 2023 | R$23.1b | R$9.2b | R$1.7b | 12.2x | 13.2x | 2.5x |
| Mon, 23 Oct 2023 | R$22.4b | R$9.1b | R$1.8b | 36.9x | 12.7x | 2.5x |
| Wed, 20 Sep 2023 | R$25.1b | R$9.1b | R$1.8b | 40.7x | 14.3x | 2.8x |
| Fri, 18 Aug 2023 | R$27.6b | R$9.1b | R$1.8b | 43.7x | 15.7x | 3x |
| Sun, 16 Jul 2023 | R$29.6b | R$8.8b | R$1.8b | 14.2x | 16.4x | 3.4x |
| Tue, 13 Jun 2023 | R$30.4b | R$8.8b | R$1.8b | 14.6x | 16.8x | 3.5x |
| Thu, 11 May 2023 | R$25.7b | R$8.8b | R$1.8b | 12.4x | 14.1x | 2.9x |
| Sat, 08 Apr 2023 | R$25.2b | R$8.6b | R$1.8b | 12.1x | 13.8x | 2.9x |
| Mon, 06 Mar 2023 | R$27.9b | R$8.5b | R$1.8b | 13.5x | 15.2x | 3.3x |
| Wed, 01 Feb 2023 | R$30.8b | R$8.0b | R$1.8b | 14.9x | 17.5x | 3.8x |
| Fri, 30 Dec 2022 | R$29.9b | R$8.0b | R$1.8b | 13.9x | 17x | 3.7x |
| Sun, 27 Nov 2022 | R$29.6b | R$8.0b | R$1.8b | 13.9x | 16.8x | 3.7x |
| Tue, 25 Oct 2022 | R$32.1b | R$7.6b | R$1.7b | 15.2x | 18.4x | 4.2x |
| Thu, 22 Sep 2022 | R$29.7b | R$7.6b | R$1.7b | 14.3x | 17x | 3.9x |
| Sat, 20 Aug 2022 | R$27.6b | R$7.6b | R$1.7b | 13.3x | 15.8x | 3.6x |
| Mon, 18 Jul 2022 | R$26.2b | R$7.2b | R$1.8b | 12x | 14.7x | 3.6x |
| Wed, 15 Jun 2022 | R$24.6b | R$7.2b | R$1.8b | 11.7x | 13.8x | 3.4x |
| Fri, 13 May 2022 | R$23.9b | R$7.2b | R$1.8b | 11.9x | 13.5x | 3.3x |
| Sun, 10 Apr 2022 | R$25.8b | R$6.8b | R$1.7b | 13.1x | 14.9x | 3.8x |
| Tue, 08 Mar 2022 | R$21.8b | R$6.8b | R$1.7b | 12.4x | 12.6x | 3.2x |
| Thu, 03 Feb 2022 | R$21.0b | R$6.3b | R$1.7b | 12.8x | 12.5x | 3.3x |
| Sat, 01 Jan 2022 | R$19.2b | R$6.3b | R$1.7b | 12x | 11.4x | 3.1x |
| Mon, 29 Nov 2021 | R$18.9b | R$6.3b | R$1.7b | 11.8x | 11.2x | 3x |
| Wed, 27 Oct 2021 | R$19.3b | R$6.3b | R$1.7b | 11.8x | 11.4x | 3.1x |
| Fri, 24 Sep 2021 | R$22.4b | R$5.7b | R$1.6b | 14x | 14.2x | 3.9x |
| Sun, 22 Aug 2021 | R$24.0b | R$5.7b | R$1.6b | 14.6x | 15.2x | 4.2x |
| Fri, 09 Jul 2021 | R$23.6b | R$5.7b | R$1.6b | 15.2x | 14.9x | 4.1x |
Price to Earnings Ratio
16.8x
Current Industry PE
- There are only 2 companies in the Brazilian Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 3.7% per year over the last three years.
- Revenues for these companies have grown 20% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Brazilian Healthcare industry?
| BR Market | 1.82% | |
| Healthcare | 8.45% | |
| Pharma | 2.22% | |
| Pharma | 2.22% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HYPE3 Hypera | R$30.14 | 2.1% +R$392.5m | -21.9% | PE11.2x | |
| OFSA3 Ouro Fino Saúde Animal Participações | R$22.18 | 4.1% +R$47.3m | -12.3% | PS1.3x |